Author:
Grávalos Cristina,Carrato Alfredo,Tobeña María,Rodriguez-Garrote Mercedes,Soler Gemma,Vieitez José Mª,Robles Luis,Valladares-Ayerbes Manuel,Polo Eduardo,Limón Mª Luisa,Safont Mª José,Martínez de Castro Eva,García-Alfonso Pilar,Aranda Enrique
Subject
Gastroenterology,Oncology
Reference25 articles.
1. Survival of patients with advanced colorectal cancer improves with the availability of fluorouracil-leucovorin, irinotecan, and oxaliplatin in the course of treatment;Grothey;J Clin Oncol,2004
2. FOLFIRI plus cetuximab versus FOLFIRI plus bevacizumab as first-line treatment for patients with metastatic colorectal cancer (FIRE-3): a randomised, open-label, phase 3 trial;Heinemann;Lancet Oncol,2014
3. Neuropathic cancer pain: what we are dealing with? How to manage it?;Esin;Onco Targets Ther,2014
4. Maintenance strategy in metastatic colorectal cancer: a systematic review;Esin;Cancer Treat Rev,2016
5. Nonclinical antiangiogenesis and antitumor activities of axitinib (AG-013736), an oral, potent, and selective inhibitor of vascular endothelial growth factor receptor tyrosine kinases 1, 2, 3;Hu-Lowe;Clin Cancer Res,2008
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献